KSI-301 phase 1b trial : Kodiak Sciences reports new safety, efficacy, and durability data
KSI-301 phase 1b trial : Kodiak Sciences said that its ongoing phase 1b clinical trial of its intravitreal anti-VEGF antibody biopolymer conjugate KSI-301 for the ... Read More
San Francisco-based fintech Taulia raises $60m in new funding round
Taulia, a US fintech company that provides working capital technology solutions, has raised $60 million in a funding round led by the Ping An Global ... Read More
BrainStorm Cell Therapeutics doses patients in NurOwn phase 3 trial in ALS
NurOwn phase 3 trial : BrainStorm Cell Therapeutics, a US biotech company engaged in developing adult stem cell therapies for neurodegenerative diseases, has completed the ... Read More
Keysight Technologies acquires Eggplant from Carlyle Group for $330m
Keysight acquisition of Eggplant : Keysight Technologies, California-based manufacturer of electronics test and measurement equipment and software,e has completed its $330 million acquisition of digital ... Read More
CoolSys buys commercial refrigeration and HVAC firm Eastern Refrigeration
CoolSys, a US refrigeration and HVAC services company backed by Ares Management, has acquired Eastern Refrigeration for an undisclosed price, to further expand its market ... Read More
Gilead to acquire stake in cancer immunotherapy company Pionyr Immunotherapeutics
Gilead Sciences has agreed to acquire a stake of 49.9% in California-based cancer immunotherapy company Pionyr Immunotherapeutics, for $275 million. The pharma major has also ... Read More
Brook and Whittle acquires printed label solutions firm Label Impressions
Brook and Whittle, a provider of pressure sensitive and shrink sleeve prime labels, has acquired California-based Label Impressions for an undisclosed price. Label Impressions provides ... Read More
Orion Real Estate acquires Lookout Pointe Apartments in Provo, Utah
Orion Real Estate Partners, a Los Angeles based real estate investment firm, has acquired Lookout Pointe Apartments, a garden-style apartment community in Provo, Utah. The ... Read More
Polycythemia vera treatment : Protagonist Therapeutics’ PTG-300 gets FDA ODD
Protagonist Therapeutics has bagged the orphan drug designation (ODD) from the US Food and Drug Administration (FDA) for PTG-300 for polycythemia vera treatment. Polycythemia vera ... Read More
Gene therapy company 4D Molecular Therapeutics raises $70m in Series C round
California-based gene therapy company 4D Molecular Therapeutics (4DMT), which is focused on adeno-associated virus (AAV) gene therapy vector discovery and product development, has raised $70 ... Read More